In comments submitted to the Department of Health and Human Services (HHS), Department of Justice (DOJ), and the Federal Trade Commission (FTC), PhRMA detailed the growing threat posed by consolidation and vertical integration across the health care markets. Our letter urges HHS, DOJ, and FTC to continue addressing the growing threat to patient interests caused by the anticompetitive practices of large PBM and insurer conglomerates.